A detailed history of Fulcrum Equity Management transactions in Colgate Palmolive CO stock. As of the latest transaction made, Fulcrum Equity Management holds 5,280 shares of CL stock, worth $493,627. This represents 0.48% of its overall portfolio holdings.

Number of Shares
5,280
Previous 5,127 2.98%
Holding current value
$493,627
Previous $497,000 10.26%
% of portfolio
0.48%
Previous 0.46%

Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 21, 2024

BUY
$95.54 - $108.77 $14,617 - $16,641
153 Added 2.98%
5,280 $548,000
Q2 2024

Jul 19, 2024

BUY
$85.85 - $98.99 $38,117 - $43,951
444 Added 9.48%
5,127 $497,000
Q1 2024

Apr 24, 2024

BUY
$79.89 - $90.05 $33,873 - $38,181
424 Added 9.96%
4,683 $421,000
Q4 2023

Jan 18, 2024

BUY
$68.87 - $79.71 $10,055 - $11,637
146 Added 3.55%
4,259 $339,000
Q3 2023

Nov 13, 2023

BUY
$71.05 - $77.96 $710 - $779
10 Added 0.24%
4,113 $292,000
Q2 2023

Jul 07, 2023

BUY
$74.38 - $81.98 $305,181 - $336,363
4,103 New
4,103 $316,000
Q1 2022

Apr 15, 2022

SELL
$72.2 - $85.22 $230,462 - $272,022
-3,192 Closed
0 $0
Q4 2021

Jan 25, 2022

SELL
$74.42 - $85.34 $6,697 - $7,680
-90 Reduced 2.74%
3,192 $272,000
Q3 2021

Jan 25, 2022

BUY
$75.58 - $84.39 $1,360 - $1,519
18 Added 0.55%
3,282 $248,000
Q2 2021

Jul 15, 2021

BUY
$78.55 - $84.59 $19,637 - $21,147
250 Added 8.29%
3,264 $266,000
Q1 2021

Apr 05, 2021

SELL
$74.44 - $84.52 $669 - $760
-9 Reduced 0.3%
3,014 $238,000
Q4 2020

Feb 22, 2021

SELL
$76.67 - $86.26 $27,141 - $30,536
-354 Reduced 10.48%
3,023 $259,000
Q3 2020

Oct 27, 2020

SELL
$73.03 - $79.47 $289,052 - $314,542
-3,958 Reduced 53.96%
3,377 $261,000
Q2 2020

Aug 17, 2020

BUY
$65.55 - $74.36 $480,809 - $545,430
7,335 New
7,335 $537,000

Others Institutions Holding CL

About COLGATE PALMOLIVE CO


  • Ticker CL
  • Exchange NYSE
  • Sector Consumer Defensive
  • Industry Household & Personal Products
  • Shares Outstandng 834,120,000
  • Market Cap $78B
  • Description
  • Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products worldwide. The company operates through two segments, Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment offers toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, condition...
More about CL
Track This Portfolio

Track Fulcrum Equity Management Portfolio

Follow Fulcrum Equity Management and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Fulcrum Equity Management, based on Form 13F filings with the SEC.

News

Stay updated on Fulcrum Equity Management with notifications on news.